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Abstract 15 
Water quality was characterised at an advanced water reclamation plant and three conventional 16 
wastewater treatment plants in Southwest Western Australia using a battery of five in vitro 17 
bioassays. The bioassay battery included endpoints for bacterial toxicity (Microtox), genotoxicity 18 
(umuC), photosynthesis inhibition (Max-I-PAM) and endocrine effects (E-SCREEN and AR-CALUX), 19 
chosen to provide an appropriately wide coverage of biological effects in the context of managed 20 
2 
 
aquifer recharge and environmental discharge of treated wastewater. Chemical analysis of 21 
hormones and pesticides using LCMSMS was performed in parallel to correlate standard analytical 22 
methods with the in vitro assessment. For two plants with surface water discharge into drains, 23 
further field work was carried out to examine in situ effects using mosquitofish (Gambusia holbrooki) 24 
as a bioindicator species for possible endocrine effects. The results show considerable cytotoxicity, 25 
phytotoxicity and estrogenicity in raw sewage, which was significantly reduced by conventional 26 
wastewater treatment. No biological response was detected to RO water, suggesting that reverse 27 
osmosis is a significant barrier to biologically active compounds. Chemical analysis and in situ 28 
monitoring revealed trends consistent with the in vitro results: chemical analysis confirms the 29 
removal trends observed by the bioanalytical tools, and in situ sampling did not reveal any evidence 30 
of endocrine disruption specifically due to discharge of treated wastewater (although other sources 31 
may be present). This study illustrates the utility of combining multiple lines of evidence, including 32 
chemical analysis, an in vitro toolbox, and in situ monitoring in the assessment of water quality.  33 
Keywords: chemical analysis; in vitro bioassay; mosquitofish; wastewater; water quality; water 34 
recycling 35 
Highlights 36 
 In vitro bioassays were combined with chemical analysis and in situ sampling. 37 
 Four Western Australian wastewater treatment plants were monitored. 38 
 Slight estrogenic endocrine disruption was detected in receiving environments. 39 
 The three lines of investigation agreed and provided a more complete assessment. 40 
 No biological response or chemicals were detected in reverse osmosis permeate. 41 
 42 
1. Introduction 43 
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There are several methods that can be used to inform environmental risk assessment. Chemical 44 
analysis is widely used and well-grounded in regulatory frameworks, but is limited by a priori 45 
selection of analytes and does not allow assessment of mixture toxicity effects. Assessment of whole 46 
animals in the receiving environment (in situ analysis) is commonly used to detect toxicants and 47 
determine mixture toxicity effects of wastewater, but raises animal ethics issues and is often limited 48 
in predictive ability due to complex interactions with environmental factors (such as seasonal 49 
variations). In vitro bioassays go some way to addressing the limitations of both chemical and in vivo 50 
analysis and share a mixture of their advantages (e.g., assessment of mixture toxicity, focus on 51 
chemical-mediated effects without interference from environmental factors, no ethical issues) and 52 
some of their disadvantages (e.g., inability to positively identify causative compounds and accurately 53 
predict whole organism effects). Bioanalytical tools also have some unique advantages, including 54 
lower detection limits and high throughput screening, and some unique disadvantages such as a lack 55 
of regulatory acceptance (Escher and Leusch 2012, Power and Boumphrey 2004). A combination of 56 
these different methods would provide valuable additional information to complement the current 57 
traditional approach. 58 
Climate change has reduced rainfall and significantly diminished water availability over the last 30 59 
years in the South West of Australia and further decline is expected over the next 50 years (CSIRO & 60 
BOM 2007). At the same time Perth (Western Australia, WA) has an increasing population and 61 
competing demands for water. Consequently local authorities are trialling Groundwater 62 
Replenishment to supplement aquifers with water reclaimed from urban wastewater at an 63 
Advanced Water Reclamation Plant (AWRP). There are also a number of rural wastewater treatment 64 
plants (WWTPs) that currently dispose of treated wastewater by discharge to the freshwater 65 
environment. The potential for environmental impacts as a result of the ecotoxicity of this effluent is 66 
not well understood. This study was undertaken as part of a comprehensive research agenda to 67 
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better understand the environmental risks associated with managed aquifer recharge (Water 68 
Corporation 2013). 69 
We investigated the suitability of using three complementary analysis (chemical analysis, in vitro 70 
bioanalysis and in situ biological monitoring) to detect biologically active compounds during 71 
wastewater treatment, with a focus on endocrine disruption. We used an "ecotoxicity toolbox" to 72 
characterise water quality through the wastewater treatment process. The toolbox includes in vitro 73 
endpoints for bacterial toxicity (Microtox), genotoxicity (umuC), photosynthesis inhibition (Max-I-74 
PAM) and endocrine effects (E-SCREEN and AR-CALUX). The bioassays were chosen to provide an 75 
appropriately wide coverage of biological effects relevant to managed aquifer recharge and 76 
environmental discharge of treated wastewater. Chemical analysis using LCMSMS of hormones and 77 
pesticides was performed in parallel to correlate standard analytical methods with the in vitro 78 
assessment. An AWRP in Perth and three WWTPs in neighbouring rural and urban communities were 79 
monitored to represent a range of treatment, water quality and end-uses. Samples were taken at 80 
various steps in the treatment train in order to characterise water quality through the treatment 81 
process. For those plants with surface water discharge into drains (WWTPs 1 and 2), further field 82 
work was carried out to examine in situ effects using mosquitofish (Gambusia holbrooki) as a 83 
bioindicator species for possible endocrine effects. 84 
The aims of this study were: 1) to analyse water reclaimed by advanced water treatment (including 85 
reverse osmosis) intended for managed aquifer recharge with a combination of chemical analysis 86 
and in vitro bioassays; 2) to analyse raw, partly and fully treated wastewater at two municipal and 87 
two rural WWTPs using chemical and in vitro methods to determine the quality of representative 88 
wastewater in WA; 3) to examine biomarkers of exposure to endocrine disrupting compounds in 89 
mosquitofish captured in drains upstream and downstream of two of those WWTPs and analyse 90 
water quality at those same sites with the in vitro bioassay battery; and 4) to compare the results of 91 
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the three methods (chemical, in vitro and in situ) and further our understanding of their value in risk 92 
assessment. 93 
2. Materials and methods 94 
2.1. Site description 95 
Four WWTPs were sampled in this study (Fig 1). The AWRP is a major urban WWTP with a small pilot 96 
plant AWRP for trial of groundwater replenishment that includes reverse osmosis (RO) treatment; 97 
WWTP 1 and 2 are small rural plants providing secondary treatment of wastewater from country 98 
towns with discharge into drains; and WWTP3 is a secondary treatment plant with infiltration to a 99 
superficial aquifer with downstream abstraction for irrigation use. The WWTPs were selected to 100 
provide a range of treatment technologies and type of end-use/receiving environment typical of 101 
Southwest WA. 102 
[INSERT FIG 1 ABOUT HERE] 103 
Several stages of the treatment trains were sampled (Fig. 1), including raw, partially and fully treated 104 
wastewater, and RO permeate at the AWRP. The AWRP was sampled in March, June, September and 105 
December 2008. The three WWTPs were sampled in June, September and December 2008 and 106 
March 2009. Discharge drains upstream and downstream of WWTP 1 and 2 and a reference site 107 
adjacent to the Serpentine National Park were also sampled in December 2008. 108 
2.2. Water sampling and extraction 109 
Quadruplicate samples were taken quarterly over a year at each location: two samples for bioassays, 110 
and two samples spiked with deuterated hormone surrogates for chemical analysis. 111 
Water samples (1 L for raw sewage, 2 L for all other samples) were collected in methanol-rinsed 112 
amber glass bottles by flow-averaged autosampler (AWRP) or by grab samples (all others) and 113 
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immediately processed. Samples were filtered (AP20 glass fibre filters; Millipore) and extracted by 114 
solid-phase extraction using 20 cc Oasis HLB cartridges using the method described in Leusch et al. 115 
(2006). In brief, cartridges were pre-conditioned with 10 mL methanol and 10 mL ultrapure water. 116 
After passing the entire water sample, the cartridges were air-dried for 2 h. They were eluted with 117 
2×10 mL methanol, evaporated to near dryness under a gentle stream of nitrogen, and reconstituted 118 
in 500 µL methanol. The eluates were analysed by in vitro bioassays and chemical methods. For the 119 
first two sampling events (March and June 2008), 10 mL acetone:hexane (1:1) was also used in 120 
addition as first conditioning solvent and last elution solvent. In September 2008, side-by-side 121 
experiments with wastewater samples showed no significant difference in chemical and 122 
bioanalytical results when using acetone:hexane and methanol vs. methanol only as conditioning 123 
and elution solvent (data not shown), and methanol only was used for the 3 remaining sampling 124 
events. 125 
2.3. Bioanalytical toolbox 126 
The Microtox assay measures inhibition of bioluminescence of the naturally-bioluminescent marine 127 
bacteria Vibrio fischeri. This inhibition is caused by acute cellular toxicity or interference with energy 128 
generation pathways, and is responsive to a wide range of toxic chemicals. The assay is used here as 129 
representative of non-specific toxicity to bacteria. The assay was adapted from ISO (2007) and 130 
performed as described in Escher et al. (2008b). The bioassay threshold (i.e., value above which 131 
adverse effects may be expected in the receiving environment) was set to 1 TU (see SI 1.1). 132 
The umuC assay measures induction of the SOS response in genetically modified Salmonella 133 
typhymurium. The SOS response is induced in response to single-stranded DNA damage. This 134 
bioassay is used here as representative of genotoxicity to bacteria, plants and animals. The assay 135 
was adapted from ISO (2000) and performed as described in Macova et al. (2011). The bioassay 136 
threshold was set to 1 GTU (see SI 1.2). The umuC assay was run both with and without a liver 137 
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enzyme fraction (S9), however the data trends were very similar (data not shown) and only the data 138 
without metabolic activation are presented here. 139 
The Max-I-PAM measures changes in photosynthetic capacity of the algae Chlorella vulgaris, and is 140 
generally responsive to herbicides. The bioassay is used as representative interference with 141 
photosynthesis, a measure of phytotoxicity. The assay was adapted from Schreiber et al. (2007) and 142 
performed as described in Escher et al. (2006). The reference compound for this assay was diuron 143 
(EC50 = 16.8 ± 1.5 µg/L) and the method detection limit was 0.03 µg/L diuron equivalent (DEQ). The 144 
bioassay threshold was set at 0.2 µg/L DEQ (see SI 1.3). 145 
The E-SCREEN assay measures proliferation of MCF7-BOS breast cancer cells (a gift of Dr Ana Soto, 146 
Tufts University), which occurs in the presence of estrogenic compounds such as estrogens and 147 
estrogen mimics. The assay is used here as representative of estrogenic endocrine disruption. The 148 
assay was adapted from (Soto et al. 1995) and performed as described in (Leusch et al. 2005). The 149 
reference compound for this assay was 17β-estradiol (E2; EC50 = 6.5 ± 0.5 ng/L) and the method 150 
detection limit was 0.02 ng/L estradiol equivalent (EEQ). The bioassay threshold was set at 0.1 ng/L 151 
EEQ (see SI 1.4). 152 
Finally the AR-CALUX assay measures induction of an androgenic reporter gene in a genetically-153 
modified human cell line, and is responsive to androgens and androgen mimics. The assay is used 154 
here as representative of androgenic endocrine disruption. The assay was adapted from Sonneveld 155 
et al. (2005) and performed as described in van der Linden et al. (2008). The reference compound for 156 
this assay was 5α-dihydrotestosterone (DHT; EC50 = 47.7 ± 3.1 ng/L) and the method detection limit 157 
was 2.5 ng/L DHT equivalent (DHTEQ). The bioassay threshold was tentatively set at 10 ng/L DHTEQ 158 
(see SI 1.5). 159 
2.4. Chemical analysis 160 
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A range of androgen and estrogen hormones were analysed by HPLC-MS/MS analysis as described in 161 
Le-Minh et al. (2010). The estrogenic and androgenic hormones analysed (with the limit of reporting) 162 
were: the androgens androstenedione (1 ng/L), androsterone (50 ng/L), etiocholanolone (100 ng/L), 163 
testosterone (1 ng/L), 5α-dihydrotestosterone (50 ng/L), testosterone propionate (5 ng/L) and 17β-164 
trenbolone (5 ng/L), and the estrogens 17β-estradiol (5 ng/L), 17α-estradiol (5 ng/L), estrone (5 165 
ng/L), estriol (50 ng/L) and 17α-ethinylestradiol (5 ng/L). 166 
Herbicides analysis was performed at Queensland Health Forensic and Scientific Services (QHFSS). 167 
The following pesticides were measured: flumeturon, diuron, simazine, atrazine, desethyl atrazine, 168 
desisopropyl atrazine, hexazinone, tebuthiuron, ametryn, prometryn, bromacil, terbutryn, 169 
metolachlor and imidacloprid. The reporting limit for all compounds was 0.025 µg/L. The compounds 170 
were analysed by HPLC-MS/MS using an AB/Sciex API300 mass spectrometer (AB/Sciex Concord, 171 
Ontario, Canada) equipped with an electrospray (TurboSpray) interface coupled to a Shimadzu 172 
LC10AD HPLC system (Shimadzu Corp., Kyoto, Japan). Separation was achieved using a 5 µm 150×3 173 
mm Aquastar column (Thermo Scientific, Australia) run at 40 ºC, and a flow rate of 0.6 mL/min with 174 
a linear gradient starting at 10% B for 1 min, ramped to 100% B in 6 min, held for 2.5 min and then 175 
set to 10% B in 15 sec and equilibrated for 4 minutes (A = 10% methanol/HPLC grade water, B = 90% 176 
methanol/HPLC grade water, both containing 5 mM ammonium acetate). The mass spectrometer 177 
was operated in positive ion multiple reaction-monitoring mode using nitrogen as the collision gas. 178 
Positive samples were confirmed by retention time and by comparing transition intensity ratios 179 
between the sample and an appropriate concentration standard from the same run. Samples were 180 
reported as positive if the two transitions were present, retention time was within 9 sec of the 181 
standard and the relative intensity of the confirmation transition was within 20% of the expected 182 
value. 183 
2.5. Mosquitofish sampling and analysis 184 
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Mosquitofish were collected in September 2008, March and July 2009 (Spring, Summer and Winter) 185 
immediately downstream of the discharge point of WWTP 1 and 2. For each WWTP an upstream site 186 
was selected for sampling with considerations of low potential of population mixing between the 187 
two sites on the same stream. Fish were also collected in the Serpentine River at a site adjacent to 188 
Serpentine National Park (reference site). 189 
On each sampling occasion up to 100 individuals were collected until the catch per unit effort 190 
became too low to justify further capture. Twenty adult males (identified by the presence of an 191 
elongated anal fin) and 6 females (identified by a black spot on the ventral side of the abdomen) 192 
were snap-frozen in liquid nitrogen. The remainder were transported on ice to the laboratory. 193 
Fish were categorised as adult male, immature male, adult female and immature female. Sex and 194 
stage of maturation based on anal fin morphology was determined using the methods described by 195 
Rawson et al. (2009). Morphometric measurements including gonopodial length (GL), pre-anal 196 
length (PAL), 6th ray length (based on Game et al. 2006), standard length and wet weight were made 197 
on mature and immature male fish.  198 
Vitellogenin was quantified in fish taken from each site in Summer (March 2009) and Winter (July 199 
2009). Where possible 20 male and 6 female fish from each sampling site were homogenised in 1:4 200 
(w:v) Tris buffer (3 mM Tris, 0.1 µM PMSF). The homogenates were centrifuged at 8000×g for 40 201 
minutes at 4 ºC. Homogenates and a salmonid vitellogenin standard (Biosense Laboratories, Bergen, 202 
Norway) were diluted (1:1000) in a carbonate/bicarbonate buffer (50 mM, pH 9.6). Samples and 203 
standard were added to wells of a clear 96-well plate and allowed to incubate for 24 h at 4 ºC. The 204 
plates were then washed with phosphate buffered saline (0.05 % Tween). A 1% BSA blocking 205 
solution was added to each well and, following 1 h incubation, the monoclonal antibody BN-5 206 
(Biosense Laboratories) was added and incubated for 1 h at 37 ºC. The plates were again washed 207 
(3×) and a goat anti-rabbit HRP conjugate (Biosense Laboratories) was added for a further 1 h 208 
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incubation at room temperature. After 5 wash cycles a peroxidase substrate (OPD fast; Sigma) was 209 
added to the wells for a 15 min dark incubation. The reaction was stopped with 2 M H2SO4 and the 210 
absorbance read immediately at 490 nm. 211 
2.6. Data analysis 212 
2.6.1. Bioanalytical data analysis 213 
Biological response in water samples was quantified by calculating their EC50 in each bioassay, 214 
expressed in units of Relative Enrichment Factor REF (calculated by dividing the sample 215 
concentration from solid phase extraction by the dilution in the assay, as described in Macova et al. 216 
(2011)). 217 
Microtox results are expressed as Toxic Unit (TU), calculated as 1/EC50(REF) of the sample; umuC 218 
results are expressed as genotoxic unit (GTU), calculated as 1/EC50(REF). Max-I-PAM, E-SCREEN and 219 
AR-CALUX results are expressed as bio-equivalents, calculated as EC50
 of the reference compound 220 
(diuron, 17β-estradiol and 5α-dihydrotesterone, respectively) divided by EC50(REF) of the sample. 221 
2.6.2. Predicted biological response 222 
In vitro responses could be predicted for estrogenicity, androgenicity and photosynthesis inhibition 223 
by multiplying the concentration of selected compounds by their relative potency (RP; determined in 224 
this study) in the relevant assay. Cytotoxicity and genotoxicity can be caused by a wide variety of 225 
compounds, and it was therefore not possible to relate those biological endpoints to chemical 226 
analysis. 227 
Predicted estrogenicity was calculated from 17β-estradiol (RP = 1), estrone (RP = 0.012) and estriol 228 
(RP = 0.071); predicted androgenicity was calculated from androstenedione (RP = 0.057), 229 
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androsterone (RP = 0.006), testosterone (RP = 0.21), testosterone propionate (RP = 0.20) and 17β-230 
trenbolone (RP = 0.50); photosynthesis inhibition was calculated from diuron (RP = 1). 231 
2.6.3. Morphological measures 232 
For in situ measurements, differences in GL and PAL were analysed using single factor analysis of 233 
covariance (ANCOVA) with the length of the fish as a covariate. The assumptions of homogeneous 234 
covariate slopes and equal variances between groups were satisfied. Sex ratios were examined using 235 
a binomial test. 236 
3. Results and discussion 237 
3.1. Bioanalytical 238 
In general, raw sewage caused high in vitro responses, however wastewater treatment effectively 239 
removed most of the activity and the treated wastewater samples were generally below bioassay 240 
threshold values (Fig. 2). At the AWRP, the aerobic and anaerobic digestion (secondary treatment) 241 
and reverse osmosis provided most of the removal, while the oxidation ditch at WWTP3 performed 242 
generally well (although it created short-lived genotoxicity). The raw sewage at the rural WWTPs 243 
(WWTP 1 and 2) was much less toxic than at the municipal plants (AWRP and WWTP3), and the 244 
pond-based treatment systems were adequate at reducing the toxicity to levels comparable to 245 
AWRP secondary-treated wastewater and WWTP3 effluent. The site downstream of WWTP2 246 
discharge induced slightly higher biological response in vitro compared with the upstream site, 247 
although it was usually below bioassay threshold levels. 248 
[INSERT FIG 2 ABOUT HERE] 249 
3.1.1. Microtox assay for bacterial toxicity 250 
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At the municipal plants (AWRP and WWTP3), raw sewage was acutely toxic to bacteria but aerobic 251 
and anaerobic digestion (at AWRP) and the oxidation ditch (at WWTP3) reduced the toxicity of the 252 
water by 89-92% and 70-91%, respectively. This suggests that toxic chemicals are either mineralised 253 
to less toxic degradation products or absorbed to sludge particles and removed from the water 254 
stream. At the rural plants (WWTP 1 and 2), raw sewage was not particularly toxic to bacteria (<0.3 255 
TU) and the effectiveness of pond-based treatment was variable. The treated wastewater samples at 256 
all plants monitored in this study were below 1 TU, indicating that only minimal acute toxicity would 257 
occur at environmental levels. Discharge of treated wastewater at WWTP 1 and 2 resulted in a 3-5× 258 
increase in baseline toxicity in the drain (Fig. 2, top right), but the response was still significantly less 259 
than 1 TU. The Microtox assay is sensitive to a wide range of compounds, with a strong correlation 260 
between "toxicity" and lipophilicity (Tang et al. 2013). The responses with environmental water 261 
samples (Fig 2, Microtox, Rivers) therefore indicates the presence of a variety of compounds, but at 262 
concentrations that are not acutely toxic to bacteria (TU < 1). 263 
RO treatment at AWRP reduced cytotoxicity of the water stream by a further 68% at least. Low level 264 
responses (<0.05 TU) were detectable in 2 out of 4 RO permeate samples and the water at the 265 
reference site (Fig 2, Microtox, "RO" and "Ref"). Low level response in highly concentrated water 266 
samples (REF > 10) with non-specific assays such as the Microtox has been reported previously 267 
(Escher et al. 2008a) and is thought to be an artefact of solvent carry-over during the SPE 268 
concentration step. It is of no environmental concern as long as a) it is not considerably above the 269 
detection limit (i.e., less than 0.1 TU) and b) no other specific and/or reactive toxicity are associated 270 
with the sample – as was the case here. 271 
These results are comparable to previous Australian studies, which reported the equivalent of 0.20 272 
TU in raw sewage, up to 0.10 TU in secondary treated wastewater, and up to 0.04 TU in tertiary 273 
treated wastewater using the Microtox assay (Macova et al. 2011, Muller et al. 2007). 274 
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3.1.2. umuC assay for genotoxicity 275 
Raw sewage contained detectable levels of genotoxicity (Fig. 2, umuC -S9). Aerobic and anaerobic 276 
digestion at AWRP resulted in a 15-44% reduction in genotoxicity. Oxidation at WWTP3 resulted in a 277 
4.9-6.2× increase in genotoxicity to levels above 1 GTU. An increase in genotoxicity in such an 278 
environment favouring the creation of reactive compounds is not unexpected, but it should be noted 279 
that it was short lived and that genotoxicity dropped below the bioassay threshold after clarification. 280 
The genotoxicity of the final wastewater was 60-75% lower than that of the raw influent, and was 281 
similar to that of the secondary wastewater at the AWRP. Genotoxicity was not commonly detected 282 
in rural wastewater (WWTP 1 and 2) and was not detected in any of the river water samples. 283 
Reverse osmosis was the most effective removal method for genotoxicity, removing at least 86% of 284 
the activity (to <0.02 TU). Genotoxicity was not detected in any of the RO permeate samples (Fig. 2). 285 
With the exception of samples from the oxidation ditch, all samples were below 1 GTU. Their 286 
discharge into the environment would therefore not be expected to produce significant genotoxicity. 287 
The samples from the oxidation ditch, however, were above 1 GTU, suggesting that if this water 288 
were discharged without further treatment (which is not the case) it may cause adverse effect in 289 
exposed microorganisms.  290 
These results are comparable to previous Australian studies, which reported the equivalent of 0.4 291 
GTU in raw sewage and less than 0.02 GTU in treated wastewater using the umuC -S9 assay (Macova 292 
et al. 2011, Muller et al. 2007). 293 
3.1.3. Max-I-PAM assay for photosynthesis inhibition 294 
Raw sewage at the municipal plants (AWRP and WWTP3) strongly inhibited photosynthesis, with the 295 
phytotoxicity above the bioassay threshold of 0.2 µg/L DEQ in most samples (Fig. 2, Max-I-PAM). 296 
Aerobic/anaerobic digestion (at AWRP) and oxidation ditch (at WWTP3) reduced phytotoxicity by 48-297 
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90% and 50-86%, respectively. Reverse osmosis removed a further 48% at least, and all RO permeate 298 
samples were below quantification limit (<0.03 µg/L DEQ). 299 
The phytotoxicity in rural raw sewage (WWTP 1 and 2) was similar, ranging from 0.04-0.23 µg/L DEQ. 300 
The overall removal efficacy with the pond-based systems was 47-59%, on average. The 301 
phytotoxicity in the treated wastewater was similar to that of the municipal WWTPs, ranging from 302 
<0.03-0.08 µg/L DEQ. Low-level photosynthesis inhibition was detected downstream of WWTP2 303 
discharge (0.06 µg/L DEQ), but not at WWTP1. All treated wastewater samples were below the 304 
bioassay threshold of 0.2 µg/L DEQ (Fig. 2). 305 
These results are comparable to previous Australian studies, which reported up to 0.22 µg/L DEQ in 306 
raw sewage, 0.05-0.28 µg/L DEQ in treated wastewater, and up to 0.04 µg/L DEQ in river water 307 
(Escher et al. 2006, Macova et al. 2011, Muller et al. 2007). Similar concentrations have been 308 
reported in Switzerland, with an average of 0.28 µg/L DEQ in raw sewage, 0.19 µg/L DEQ in treated 309 
wastewater, and up to 0.23 µg/L DEQ in river water (Escher et al. 2008b). 310 
3.1.4. E-SCREEN assay for estrogenic EDCs 311 
Raw sewage at the municipal plants (AWRP and WWTP3) was highly estrogenic (Fig. 2, E-SCREEN). 312 
Aerobic and anaerobic digestion (at AWRP) reduced estrogenicity by 82-98%, consistent with 313 
expectations that estrogens would mineralise and/or absorb to sludge (Andersen et al. 2003). The 314 
estrogenicity in the secondary treated wastewater from the municipal treatment plants (AWRP and 315 
WWTP3) was still several orders of magnitude higher than a bioassay based threshold of 0.1 ng/L 316 
EEQ, suggesting that release of these wastewaters without dilution could cause estrogenic effects in 317 
the receiving environment. 318 
Reverse osmosis removed at least 39% of the remaining estrogenicity, and all RO permeate samples 319 
were below detection limit (<0.02 ng/L EEQ).  320 
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Estrogenicity at the rural WWTPs (WWTP 1 and 2) was very low, with less than 4.8 ng/L EEQ in raw 321 
sewage and <0.02 ng/L EEQ at all other stages. Only river samples upstream and downstream of 322 
WWTP2 had detectable estrogenicity, with a 2.2× increase at the downstream site (up to the 323 
bioassay threshold of 0.1 ng/L; Fig. 2, E-SCREEN, "DN2"). This level of estrogenicity suggests that low 324 
level estrogenic endocrine effects may be detected in fish collected from that site (see Sections 3.3 325 
and 3.4.2), as well as the existence of upstream sources of estrogenic compounds. 326 
The concentrations are consistent with previous Australian studies, which reported up to 74 ng/L 327 
EEQ in raw sewage, up to 1.6 ng/L EEQ in secondary treated wastewater, up to 0.47 ng/L EEQ in river 328 
water, and less than 0.06 ng/L EEQ in reclaimed water in the E-SCREEN assay (Leusch et al. 2010, 329 
Macova et al. 2011, Tan et al. 2007). 330 
3.1.5. AR-CALUX assay for androgenic EDCs 331 
Raw sewage contained high levels of androgenic compounds, but wastewater treatment was 332 
effective at reducing the androgenicity in all treated wastewater samples to below detection limit 333 
(<2.5 ng/L DHTEQ). None of the environmental samples had any detectable level of androgenicity, 334 
suggesting that androgenic endocrine disruption is unlikely in organisms in the receiving 335 
environment. All RO permeate samples were also below detection limit. 336 
No data could be found on androgenicity in Australian waters, but our results are comparable with a 337 
European study, which reported up to 86 ng/L DHTEQ in raw sewage and 0.75-0.83 ng/L DHTEQ in 338 
treated wastewater (van der Linden et al. 2008). 339 
3.2. Chemical 340 
3.2.1. Androgens and estrogens 341 
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Several androgen and estrogen hormones were detected in raw and partially treated wastewater 342 
(Table 1). Overall, the chemical data indicates good removal by secondary treatment and, with a few 343 
exceptions, hormones were not detected in treated wastewater. Several androgens were routinely 344 
detected (particularly the naturally occurring androstenedione, androsterone, etiocholanolone and 345 
testosterone). Estrone was the only estrogen commonly detected, including in secondary treated 346 
wastewater (Table 1). Three hormones (dihydrotestosterone, 17α-estradiol and 17α-347 
ethynylestradiol) were not detected in any of the samples (reporting limits of 50, 5 and 5 ng/L, 348 
respectively). None of the monitored chemicals were detected in RO permeate. 349 
[INSERT TABLE 1 ABOUT HERE] 350 
The concentrations and observed removal during treatment at the four WWTPs investigated in this 351 
study are consistent with previous reports in Australian wastewater (Allinson et al. 2010). The only 352 
unusual finding was the observation of the androgenic steroid 17β-trenbolone in raw influents and 353 
primary treated wastewater (although it was not observed in secondary or more highly treated 354 
wastewater). 17β-Trenbolone is the metabolite of the hormone growth promoter 17β-trenbolone 355 
acetate used in beef cattle, suggesting that agricultural run-off may be the source of this chemical. 356 
The trenbolone concentrations detected here were in the same range as those previously reported 357 
in runoff from beef feedlot in the USA (Durhan et al. 2006). 358 
3.2.3.Herbicides 359 
Of all the pesticides monitored (section 2.2.2), only diuron and metolachlor were detected above the 360 
reporting limit (0.025 µg/L).  361 
Diuron was detected at most WWTPs, at concentrations up to 0.15 µg/L. Conventional wastewater 362 
treatment was not particularly effective, and concentrations of diuron in treated wastewaters were 363 
in the same range as in the influent. Reverse osmosis was, however, effective at removing diuron to 364 
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below quantification limit. Metolachlor was detected at the AWRP only, at up to 0.12 µg/L in raw 365 
sewage. Primary and secondary treatment removed more than 78% of the compound. 366 
3.3. Mosquitofish 367 
There were significant differences between sex ratios at both WWTPs in the September (Spring) and 368 
March (Summer) sampling periods but not during the July (Winter) sampling period (Table 2). 369 
However, the trends were not consistent between sampling periods and appear to reflect 370 
population differences rather than any WWTP impact. 371 
[INSERT TABLE 2 ABOUT HERE] 372 
There was no consistent effect on GL or PAL at either WWTP 1 or 2. There were no significant 373 
differences between either the GL (ANCOVA, pSep = 0.214, pJul = 0.472) or PAL (ANCOVA, pSep = 0.546, 374 
pJul = 0.091) of fish captured upstream and downstream of WWTP1 in September 2008 or July 2009. 375 
Fish from upstream and downstream of WWTP1 in March 2009 had similar GLs (ANCOVA, p = 0.083). 376 
In March 2009 male fish had significantly shorter PALs downstream of WWTP1 compared to fish at 377 
the upstream site (ANCOVA, p = 0.038). While this potentially represents an androgenic effect, it was 378 
not repeated in any of the other endpoints at any other of the sampling periods. There was also no 379 
significant difference between the upstream and downstream sites at WWTP2 in terms of GL 380 
(ANCOVA, pSep = 0.112, pMar = 0.323, pJul = 0.472) or PAL (ANCOVA, pSep = 0.104, pMar = 0.324, pJul = 381 
0.091). However, when compared to fish from the reference site, fish from downstream of WWTP2 382 
had longer gonopodia (ANCOVA, p = 0.001) and longer PAL (ANCOVA, p < 0.001).  383 
Vitellogenin (Vtg), a precursor to egg yolk, is naturally produced by mature female fish in the lead up 384 
to the reproductive season (Summer). Vtg was not detectable in plasma of female fish in Winter (Fig. 385 
3, right, grey bars) but commonly detected in females in Summer (except at the reference site; Fig. 3, 386 
right, black bars). Vtg is not normally produced in male fish except upon exposure to estrogenic 387 
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compounds (Sumpter and Jobling 1995). If males were exposed to estrogenic compounds, it could be 388 
expected that Vtg would be produced irrespective of the season. Plasma Vtg was not detected in 389 
male mosquitofish at WWTP1 and the reference site (Fig. 3, left); however, it was detected in both 390 
Summer and Winter sampling periods upstream and downstream of WWTP2 (at low levels 391 
compared to female fish). This indicates that these fish were exposed to estrogenic compounds. 392 
Given that fish both upstream and downstream of the WWTP outlet displayed this response, it is not 393 
possible to attribute this to the presence of the outlet alone. It is likely that upstream sources of 394 
EDCs are acting, with the outlet contributing to the EDC load at the downstream site. 395 
[INSERT FIG 3 ABOUT HERE] 396 
3.4. Comparison of the different methods 397 
3.4.1. Comparison of chemical and in vitro bioassay analysis 398 
Using the concentrations of chemicals and their known potency in the bioassays, it was possible to 399 
calculate predicted activity and compare it with the measured response in vitro. This could be done 400 
for estrogenicity based on estrogen hormones, androgenicity based on androgen hormones and 401 
photosynthesis inhibition based on diuron (Fig 4). 402 
[INSERT FIG 4 ABOUT HERE] 403 
The natural hormones 17β-estradiol and estriol accounted for most of the predicted estrogenicity in 404 
raw and partially treated wastewater (92-94%), while estriol and estrone accounted for most of the 405 
predicted estrogenicity in secondary treated wastewater (90%). 406 
When comparing predicted with measured estrogenicity, 30 out of 66 data points (45%) were within 407 
an order of magnitude from isometric agreement (i.e., within the dotted lines in Fig 4). Out of the 36 408 
data points that were more than one order of magnitude away, 26 predicted much higher 409 
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estrogenicity than was measured (24 of those at WWTP 1 and 2) and 10 measured much higher 410 
estrogenicity than predicted. The chemical detection limit for the potent estrogen 17α-411 
ethinylestradiol was comparatively high (5 ng/L) and it is likely that this compound occurring just 412 
below the chemical detection limit explains most of the occurrences of measured higher than 413 
predicted estrogenicity. The presence of anti-estrogens may explain the poor agreement between 414 
predicted and measured estrogenicity was found at the rural WWTPs 1 and 2. 415 
Testosterone, androstenedione and 17β-trenbolone were evenly responsible for 83-93% on average 416 
of the predicted androgenicity in raw and primary treated wastewater, while androstenedione alone 417 
was responsible for 67-78% of the predicted androgenicity in partially treated and secondary treated 418 
wastewater. 419 
Much better agreement between predicted and measured response was obtained for androgenicity, 420 
with all 62 data points falling within an order of magnitude of isometric agreement (Fig 2). This 421 
suggests that the 5 androgens measured here by chemical analysis are responsible for most of the 422 
androgenicity in the AR-CALUX assay. 423 
When comparing predicted and measured photosynthesis inhibition, there was generally good 424 
agreement between the predicted and measured diuron equivalent (with 67 out of 83 data points 425 
within an order of magnitude of isometric agreement, Fig 4). There were no samples where the 426 
response was lower than predicted, however the measured response was much higher than 427 
predicted for 19% of samples. This is particularly true for raw sewage samples, and suggests the 428 
presence of other phytotoxic compounds not accounted for by chemical analysis. Note that 429 
measured and predicted photosynthetic inhibition in all secondary and treated wastewater samples 430 
were in good agreement, indicating that diuron was the most significant contributor to phytotoxicity 431 
in these samples. This suggests that phytotoxic compounds present in raw sewage were removed by 432 
wastewater treatment, but that diuron was more persistent. 433 
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3.4.2. Comparison of in situ monitoring and analysis of wastewater at WWTP 1 and 2 434 
There was a good parallel between the findings of the in situ monitoring and both chemical and in 435 
vitro bioassay analysis of the treated wastewaters and rivers. Overall, the chemical and in vitro 436 
bioassay analysis showed good removal of endocrine-active substances (both estrogenic and 437 
androgenic) by wastewater treatment to produce low to undetectable concentrations of estrogenic 438 
and androgenic EDCs (Table 1 and Fig 2). Low estrogenicity was detected in the drain upstream and 439 
downstream of WWTP2, with the downstream site slightly higher than the upstream site (Fig 2, E-440 
SCREEN). Based on these findings, slight estrogenic effects were expected in fish in the WWTP2 drain 441 
but not in the WWTP1 drain or at the reference site. This is indeed what was found (Fig 3).  442 
All three lines of evidence (chemical analysis, in vitro bioassay analysis and in situ whole fish 443 
monitoring) suggest that treatment at the rural WWTPs monitored in this study is adequate to 444 
remove EDCs present in raw sewage to concentrations where they are no longer of concern. In vitro 445 
bioassays and in situ monitoring suggest the occurrence of sources of estrogenic EDCs at WWTP2. In 446 
vitro bioassays and chemical analysis indicate that the secondary treated wastewater from AWRP 447 
and WWTP3 would dilution prior to environmental discharge, otherwise estrogenic effects may 448 
arise. Note however that RO treatment was very effective at removing the residual estrogenicity and 449 
that the RO permeate did not elicit any response in the E-SCREEN assay (<0.02 ng/L EEQ). 450 
4. Conclusions 451 
There was significant cytotoxicity, phytotoxicity and estrogenicity in raw sewage, but most of this 452 
activity was greatly reduced during standard wastewater treatment. No biological response was 453 
detected to RO water, suggesting that reverse osmosis was a significant barrier to biologically active 454 
compounds. Chemical analysis and in situ monitoring provided results consistent with the in vitro 455 
results: chemical analysis confirmed the removal trends observed by the bioanalytical tools, and in 456 
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situ sampling did not reveal any evidence of endocrine disruption specifically due to discharge of 457 
treated wastewater (although other sources may be present). 458 
This study has demonstrated the utility of combining multiple lines of evidence, including chemical 459 
analysis, an in vitro ecotoxicity toolbox, and in situ monitoring in the assessment of water quality. 460 
Biomarkers of exposure (in vitro) and effect (in vivo or in situ) are complementary and together 461 
provide information with a high level of ecological relevance. It is important however that the assays 462 
are used with careful consideration of confounding factors and with a high degree of knowledge of 463 
study species and environmental conditions. 464 
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Tables and Figures 563 
Table 1. Concentrations of androgens, estrogens and herbicides monitored (in ng/L). Values are mean ± SD of 2 independent samples; except where 564 
indicated as (a) where n=1. "AWRP" = Advanced Water Reclamation Plant; "WWTP" = Wastewater Treatment Plant; "Inf" = Influent (raw sewage); "1º" = 565 
Primary treated wastewater; "2º" = Secondary treated wastewater; "RO" = Reverse osmosis permeate; "IP" = In-plant sample; "Eff" = Effluent (treated 566 
wastewater); "NA" = Not available. 567 
  AWRP    WWTP1   WWTP2   WWTP3   
Chemical Sampling 
date 
Inf 1º 2º RO Inf IP Eff Inf IP Eff Inf IP Eff 
Androstenedione Mar-08 340 ± 91 170 ± 2.8 6.3 ± 0.6 <1 NA NA NA NA NA NA NA NA NA 
Jun-08 490 ± 90 400 ± 25 7.2 ± 0.9 <1 54 ± 7.8 14 ± 4.9 17 ± 0.7 180 ± 4.9 14 ± 1.4 10 ± 0.7 270 ± 9.9 15 ± 0.7 7.6 ± 0.4 
Sep-08 310 ± 120 290 ± 7.1 13 ± 0.7 <1 69 ± 7.1 4.8 ± 0.3 3.3 ± 0.7 14 ± 2.1 <1 <1 30 ± 1.4 20 ± 2.1 5.1 ± 0.6 
Mar-09 NA NA NA NA <1 <1 <1 <1 <1 <1 170 ± 1.4 15 ± 0.1 3.2 ± 0.2 
Androsterone Mar-08 NA NA <50 <50 NA NA NA NA NA NA NA NA NA 
Jun-08 NA NA <50 <50 430 ± 110 <50 <50 800 ± 74 70 ± 21 67 ± 3.5 5400 ± 1300 86
(a) 
<50 
Sep-08 1600 ± 690 1500 ± 49 <50 <50 610 ± 17 <50 <50 78 ± 2.8 <50 <50 460 ± 7.7 <50 <50 
Mar-09 NA NA NA NA <50 <50 <50 280 ± 1.4 <50 <50 1600 ± 14 <50 <50 
Etiocholanolone Mar-08 NA NA <100 <100 NA NA NA NA NA NA NA NA NA 
Jun-08 NA NA <100 <100 420 ± 32 <100 <100 980 ± 14 180 ± 20 180 ± 52 4900 ± 1500 <100 <100 
Sep-08 3000 ± 270 1600 ± 70 180 ± 25 <100 940 ± 28 <100 <100 150 ± 4.9 <100 <100 1100 ± 17 470 ± 26 180 ± 96 
Mar-09 NA NA NA NA 290 ± 0.7 <100 <100 1000 ± 2.1 <100 <100 2600 ± 7.1 <100 <100 
Testosterone Mar-08 76 ± 2.8 49 ± 1.4 <1 <1 NA NA NA NA NA NA NA NA NA 
Jun-08 110 ± 1.4 130 ± 0.3 <1 <1 5.4 ± 0.5 <1 <1 9.2 ± 0.1 <1 <1 91 ± 1.4 <1 <1 
Sep-08 91 ± 24 100 ± 0.7 <1 <1 7.8 ± 0.6 <1 <1 <1 <1 <1 13 ± 0.7 4.9 ± 0.8 1.2 ± 0.1 
Mar-09 NA NA NA NA <1 <1 <1 <1 <1 <1 59 ± 0.5 2.5 ± 0.4 2.4 ± 0.1 
Dihydrotestosterone Mar-08 <50 <50 <50 <50 NA NA NA NA NA NA NA NA NA 
Jun-08 <50 <50 <50 <50 <50 <50 <50 <50 <50 <50 <50 <50 <50 
Sep-08 <50 <50 <50 <50 <50 <50 <50 <50 <50 <50 <50 <50 <50 
Mar-09 NA NA NA NA <50 <50 <50 <50 <50 <50 <50 <50 <50 
Testosterone 
propionate 
Mar-08 <5 <5 <5 <5 NA NA NA NA NA NA NA NA NA 
Jun-08 <5 <5 <5 <5 <5 <5 <5 <5 <5 <5 <5 <5 <5 
Sep-08 17 ± 3.5 22 ± 2.1 <5 <5 9.2 ± 0.8 <5 <5 <5 <5 <5 14 ± 2.8 <5 <5 
Mar-09 NA NA NA NA <5 <5 <5 <5 <5 <5 <5 <5 <5 
17β-Trenbolone Mar-08 <5 <5 <5 <5 NA NA NA NA NA NA NA NA NA 
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Jun-08 <5 <5 <5 <5 <5 <5 <5 24 ± 2.1 <5 <5 64 ± 12 <5 <5 
Sep-08 120 ± 27 110 ± 5.7 <5 <5 <5 <5 <5 13 ± 0.7 <5 <5 48 ± 5.6 <5 <5 
Mar-09 NA NA NA NA <5 <5 <5 <5 <5 <5 <5 <5 <5 
17β-Estradiol Mar-08 <5 <5 <5 <5 NA NA NA NA NA NA NA NA NA 
Jun-08 <5 <5 <5 <5 <5 <5 <5 <5 <5 <5 29 ± 1.4 8
(a) 
<5 
Sep-08 24 ± 7.8 19 ± 1.4 <5 <5 <5 <5 <5 <5 <5 <5 80 ± 4.9 23 ± 2.8 <5 
Mar-09 NA NA NA NA <5 <5 <5 <5 <5 <5 <5 <5 <5 
17α-Estradiol Mar-08 <5 <5 <5 <5 NA NA NA NA NA NA NA NA NA 
Jun-08 <5 <5 <5 <5 <5 <5 <5 <5 <5 <5 <5 <5 <5 
Sep-08 <5 <5 <5 <5 <5 <5 <5 <5 <5 <5 <5 <5 <5 
Mar-09 NA NA NA NA <5 <5 <5 <5 <5 <5 <5 <5 <5 
Estrone Mar-08 NA 220 ± 9.2 25 ± 5.6 <5 NA NA NA NA NA NA NA NA NA 
Jun-08 NA NA 34 ± 4.2 <5 32 ± 4.9 30 ± 14 37 ± 9.2 430 ± 160 160 ± 26 77 ± 34 NA 95
(a)
 100 ± 110 
Sep-08 390 ± 180 280 ± 59 67 ± 2.8 <5 74 ± 6.4 18 ± 2.1 13 ± 7.1 31 ± 3.5 20 ± 0.7 <5 NA 60 ± 2.1 <5 
Mar-09 NA NA NA NA 35 ± 2.1 <5 <5 57 ± 1.9 <5 <5 310 ± 5.7 18 ± 0.9 16 ± 0.6 
Estriol Mar-08 <50 <50 <50 <50 NA NA NA NA NA NA NA NA NA 
Jun-08 <50 <50 <50 <50 <50 <50 <50 <50 <50 <50 <50 <50 <50 
Sep-08 820 ± 460 800 ± 7.1 69 ± 5 <50 260 ± 18 190 ± 17 170 ± 20 93 ± 24 140 ± 7.1 58 ± 11 620 ± 17 89 ± 9.2 <50 
Mar-09 NA NA NA NA <50 <50 <50 <50 <50 <50 <50 <50 <50 
17α-Ethinylestradiol Mar-08 <5 <5 <5 <5 NA NA NA NA NA NA NA NA NA 
Jun-08 <5 <5 <5 <5 <5 <5 <5 <5 <5 <5 <5 <5 <5 
Sep-08 <5 <5 <5 <5 <5 <5 <5 <5 <5 <5 <5 <5 <5 
Mar-09 NA NA NA NA <5 <5 <5 <5 <5 <5 <5 <5 <5 
Diuron Mar-08 NA NA NA NA NA NA NA NA NA NA NA NA NA 
Jun-08 NA NA NA NA <25 26 ± 0.1 <25 <25 <25 <25 <25 26 ± 18 29 ± 4.1 
Sep-08 38 ± 6.1 44 ± 7.6 50 ± 2.1 <25 <25 <25 <25 <25 <25 <25 <25 32 ± 27 55 ± 8.9 
Dec-08 100 ± 18 150 ± 16 130 ± 5.3 <25 <25 NA <25 <25 NA <25 32 ± 2.4 78 ± 11 64 ± 1.9 
Mar-09 NA NA NA NA 39 ± 0.1 36 ± 3.5 <25 30 ± 8 32 ± 0.3 <25 <25 25 ± 17 28 ± 2.5 
Metolachlor Mar-08 NA NA NA NA NA NA NA NA NA NA NA NA NA 
Jun-08 NA NA NA NA <25 <25 <25 <25 <25 <25 <25 <25 <25 
Sep-08 120 ± 24 76 ± 0.1 26 ± 0.5 <25 <25 <25 <25 <25 <25 <25 <25 <25 <25 
Dec-08 32 ± 2.4 29 ± 1.1 <25 <25 <25 NA <25 <25 NA <25 <25 <25 <25 




Table 2. Population and morphometric endpoints for mosquitofish captured upstream and 569 
downstream of WWTPs 1 and 2 and at a reference site ("Ref"). "GL" = gonopodial length; "PAL" = 570 
pre-anal length (distance from the gonopodium to the snout). Values for GL and PAL are average ± 571 
SEM. * Statistically different from corresponding upstream site (α=0.05). † Statistically different from 572 
reference site (α=0.05). 573 
  WWTP1  WWTP2  Reference 









Males (%) Sep 2008 28 (14%) 14 (16%) 84 (23%) 11 (12%) 5 (6%) 
 Mar 2009 48 (34%) 16 (16%) 40 (31%) 37 (29%) 47 (34%) 
 Jul 2009 6 (38%) 5 (22%) 50 (23%) 14 (19%) 9 (21%) 
GL (mm) Sep 2008 6.83 ± 0.11 6.76 ± 0.08 6.79 ± 0.06 7.05 ± 0.09 6.97 ± 0.24 
 Mar 2009 6.90 ± 0.07 6.91 ± 0.12 7.04 ± 0.08 7.46 ± 0.07 † 7.15 ± 0.08 
 Jul 2009 7.00 ± 0.23 6.75 ± 0.28 6.55 ± 0.68 6.76 ± 0.15 6.78 ± 0.15 
PAL (mm) Sep 2008 8.93 ± 0.17 8.64 ± 0.09 8.67 ± 0.09 9.71 ± 0.22 9.37 ± 0.33 
 Mar 2009 9.48 ± 0.10 † 9.04 ± 0.18 * 9.56 ± 0.10 10.13 ± 0.11 † 9.54 ± 0.11 
 Jul 2009 9.24 ± 0.29 8.80 ± 0.40 9.11 ± 0.11 9.64 ± 0.18 9.20 ± 0.24 
 574 




Figure 1. Treatment train and sampling locations. "AWRP" = Advanced Water Reclamation Plant; 577 
"WWTP" = Wastewater Treatment Plant; "Inf" = Influent (raw sewage); "1º" = Primary treated 578 
wastewater; "2º" = Secondary treated wastewater; "RO" = Reverse osmosis permeate; "IP" = In-plant 579 
sample; "Eff" = Effluent (treated wastewater). 580 




Figure 2. Bioanalytical results. The dotted line represents the bioassay threshold above which the in 583 
vitro response is expected to lead to adverse effects in exposed organisms. "AWRP" = Advanced 584 
Water Reclamation Plant; "WWTP" = Wastewater Treatment Plant; "Inf" = Influent (raw sewage); 585 
"1º" = Primary treated wastewater; "2º" = Secondary treated wastewater; "RO" = Reverse osmosis 586 
permeate; "IP" = In-plant sample; "Eff" = Effluent (treated wastewater); "UP1" and "DN1" = 587 
Upstream and downstream of WWTP1, respectively; "UP2" and "DN2" = Upstream and downstream 588 
of WWTP2, respectively; "Ref" = Reference site; "NA" = Not available; "BQL" = Below quantification 589 
limit (quantification limit specified in Table 1). n =2 independent samples. 590 




Figure 3. Relative vitellogenin content of male (left) and female (right) mosquitofish from upstream 593 
and downstream of WWTP1 ("UP1" and "DN1", respectively) and WWTP2 ("UP2" and "DN2", 594 
respectively) and at the reference site ("Ref"). Black bars = Summer (Mar 09), grey bars = winter (Jul 595 
09). "BQL" = Below Detection Limit. 596 




Figure 4. Comparison of predicted vs. measured estrogenicity (as 17β-estradiol equivalent, EEQ; top), 599 
androgenicity (as dihydrotestosterone equivalent, DHTEQ; middle) and photosynthesis inhibition (as 600 
diuron equivalent, DEQ; bottom). The predicted in vitro response was calculated from chemical 601 
concentrations of selected compounds multiplied by the potency of each compound in the relevant 602 
assay. Predicted estrogenicity was calculated from 17β-estradiol (RP = 1), estrone (RP = 0.012) and 603 
estriol (RP = 0.071) concentrations; predicted androgenicity was calculated from androstenedione 604 
(RP = 0.057), androsterone (RP = 0.006), testosterone (RP = 0.21), testosterone propionate (RP = 605 
0.20) and 17β-trenbolone (RP = 0.50); photosynthesis inhibition was calculated from diuron alone 606 
(RP = 1). "AWRP" = Advanced Water Reclamation Plant; "WWTP" = Wastewater Treatment Plant.  = 607 
Influent (raw sewage; "Inf");  = Primary treated wastewater ("1º");  = Secondary treated 608 
wastewater ("2º");  = Effluent ("RO" and "Eff");  = In-plant sample ("IP"). Dark gray areas at the 609 
bottom left of each graph indicates below detection limit of both methods; light gray area at the 610 
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bottom and left of each graph indicates areas below the bioanalytical quantification limit and 611 
chemical quantification limit, respectively. 612 
